Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linezolid vs Aqueous Crystalline Penicillin G Sodium for Neurosyphilis
ChiCTR2600122020Phase 2Not yet recruiting
- Sponsor
- Hospital for Skin Diseases, Chinese Academy of Medical Sciences
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of linezolid in neurosyphilis and syphilis (2 arms), sponsored by Hospital for Skin Diseases, Chinese Academy of Medical Sciences. Primary endpoint: Composite endpoint of cure. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
linezolid
03
Conditions
neurosyphilissyphilis
Beyond the preview
Go deeper on ChiCTR2600122020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600122020.